Richard O Snyder

Title: The Innovations of Richard O Snyder

Introduction

Richard O Snyder is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of gene therapy, holding a total of 8 patents. His work focuses on the production and efficiency of recombinant adeno-associated virus (rAAV) vectors, which are crucial for gene therapy applications.

Latest Patents

One of his latest patents involves the production of recombinant AAV virions. This patent describes a method for generating stocks of infectious rAAV using engineered yeast strains, bacterial strains, and bacteriophages that express the necessary AAV proteins. The method allows for the generation of rAAV virions of various serotypes and pseudotypes in both prokaryotic and eukaryotic cells. Another significant patent focuses on methods for increasing the efficiency of recombinant AAV production. This invention outlines techniques for regulating the expression of AAV REP and CAP proteins, which enhances the production of high titre stocks of rAAV. The methods can be utilized in gene therapy to transfer genetic information into host cells, aiding in the management of human diseases.

Career Highlights

Richard O Snyder has worked with notable organizations such as Cell Genesys, Inc. and the University of Florida Research Foundation, Incorporated. His career has been marked by a commitment to advancing the field of gene therapy through innovative research and development.

Collaborations

Throughout his career, Snyder has collaborated with esteemed colleagues, including Richard Jude Samulski and Xiao Xiao. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Richard O Snyder's contributions to the field of gene therapy through his innovative patents and collaborations have made a significant impact. His work continues to influence the development of effective treatments for genetic disorders.